- Home
- PHIO vs IBIO Comparison
PHIO vs IBIO Comparison
Compare PHIO & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHIO
- IBIO
- Stock Information
- Founded
- PHIO 2011
- IBIO 2008
- Country
- PHIO United States
- IBIO United States
- Employees
- PHIO N/A
- IBIO N/A
- Industry
- PHIO Biotechnology: Pharmaceutical Preparations
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- PHIO Health Care
- IBIO Health Care
- Exchange
- PHIO Nasdaq
- IBIO Nasdaq
- Market Cap
- PHIO 8.6M
- IBIO 9.3M
- IPO Year
- PHIO N/A
- IBIO N/A
- Fundamental
- Price
- PHIO $2.00
- IBIO $0.77
- Analyst Decision
- PHIO Strong Buy
- IBIO Strong Buy
- Analyst Count
- PHIO 1
- IBIO 3
- Target Price
- PHIO $4.00
- IBIO $4.87
- AVG Volume (30 Days)
- PHIO 875.3K
- IBIO 776.1K
- Earning Date
- PHIO 05-15-2025
- IBIO 05-02-2025
- Dividend Yield
- PHIO N/A
- IBIO N/A
- EPS Growth
- PHIO N/A
- IBIO N/A
- EPS
- PHIO N/A
- IBIO N/A
- Revenue
- PHIO N/A
- IBIO $375,000.00
- Revenue This Year
- PHIO N/A
- IBIO $36.00
- Revenue Next Year
- PHIO N/A
- IBIO N/A
- P/E Ratio
- PHIO N/A
- IBIO N/A
- Revenue Growth
- PHIO N/A
- IBIO 650.00
- 52 Week Low
- PHIO $0.97
- IBIO $0.64
- 52 Week High
- PHIO $9.79
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- PHIO 54.98
- IBIO 30.08
- Support Level
- PHIO $1.71
- IBIO $0.70
- Resistance Level
- PHIO $2.08
- IBIO $0.83
- Average True Range (ATR)
- PHIO 0.13
- IBIO 0.06
- MACD
- PHIO 0.01
- IBIO 0.08
- Stochastic Oscillator
- PHIO 76.32
- IBIO 41.18
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.